Atripla (Efavirenz Emtricitabine Tenofovir)
Brand: Atripla
Active Ingredient(s): Efavirenz Emtricitabine Tenofovir
Strength: 600 mg / 200 mg / 300 mg
Pack Size: 30 Tablets
Store at room temperature.
DIN: 02300699
Manufacturer: Gilead Sciences Inc. (Canada)
Alternatives: Apo Efav Emtr Tenof – Mylan Efavir/Emtri/Teno – Auro Efavirenz Emtricitabine Tenofovir
$1,607.00
*A valid prescription is required for Rx items.
Description
Atripla (Efavirenz Emtricitabine Tenofovir) is a combination of antiretroviral drugs. It is typically used to treat HIV (human immunodeficiency virus infection which is a virus that attacks the body’s immune system). HIV is the virus responsible for acquired immune deficiency syndrome (AIDS). It may also have other uses.
Additional information
Atripla (Efavirenz Emtricitabine Tenofovir) is typically used once daily. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you forget a dose, contact your pharmacist. Administer on an empty stomach, dosing at bedtime may improve tolerability of symptoms. WARNING: Not recommended in patients with moderate or severe liver impairment. Use caution in patients with mild liver impairment. Use is not recommended in patients with renal (kidney) impairment. Use with caution in patients with a history of seizure disorders (uncontrolled electrical disturbance in the brain). In addition to its desired action, Atripla (Efavirenz Emtricitabine Tenofovir) may cause some side effects, notably: It may cause abnormal dreams, high blood cholesterol level, depression, fatigue, dizziness, headache, anxiety, insomnia It may cause skin rash, high blood glucose (sugar) level It may cause diarrhea, nausea, vomiting, liver damage It may cause upper respiratory tract infections (coughing, runny nose, sneezing and throat pain) Contraindications: Hypersensitivity to efavirenz, emtricitabine, tenofovir disoproxil fumarate or any component of the formulation, coadministration with voriconazole or elbasvir/grazoprevir Taking Atripla (Efavirenz Emtricitabine Tenofovir) during pregnancy may be harmful for the baby. Women of childbearing potential should use an effective contraceptive method. There is no available data regarding the harm of Atripla (Efavirenz Emtricitabine Tenofovir) for the fetus, therefore it is not recommended to use it. Pregnant women should not use this product (especially in the first trimester). If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. A treatment with Atripla (Efavirenz Emtricitabine Tenofovir) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Atripla (Efavirenz Emtricitabine Tenofovir)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews